ArticleCureus2024

Dalbavancin as a Viable Alternative for Addressing Treatment Adherence in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Case Report.

Michael Sabina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.